The importance of ‘state-of-the-art’ cost-of-illness studies. Comment on: The economic burden of gout: A systematic review
2016 ◽
Vol 45
(4)
◽
pp. e9
◽
Keyword(s):
Keyword(s):
Keyword(s):
2012 ◽
Vol 45
(4)
◽
pp. 476-491
◽
Keyword(s):
2015 ◽
Vol 44
(5)
◽
pp. 531-541
◽
2010 ◽
Vol 121
(4)
◽
pp. 243-259
◽
Keyword(s):